biosimilars Archives -

https://pharmaphorum.com/news/us-eyes-shorter-exclusivity-for-biologic-drugs-in-trade-pact-report/

Celltrion gears up for subcutaneous infliximab launch in Europe

https://pharmaphorum.com/views-analysis-market-access/celltrion-gears-up-for-subcutaneous-infliximab-launch-in-europe/

FDA approves latest Humira near-copy, as dozens of biosimilars head for market

https://pharmaphorum.com/news/fda-approves-latest-humira-near-copy-as-dozens-of-biosimilars-head-for-market/

https://pharmaphorum.com/news/sandoz-buys-aspens-japanese-generics-business-for-up-to-434-million/

Biogen signs marketing deal for two ophthalmology biosimilars

https://pharmaphorum.com/news/biogen-signs-marketing-deal-for-two-ophthalmology-biosimilars/

FDA finally approves Sandoz’s Neulasta biosimilar, but will Amgen put up a fight?

https://pharmaphorum.com/news/fda-finally-approves-sandozs-neulasta-biosimilar-but-will-amgen-put-up-a-fight/

Biosimilars in the UK: where are we now and where does the NHS want to go?

https://pharmaphorum.com/views-analysis-market-access/biosimilars-in-the-uk/

https://pharmaphorum.com/news/novartis-strikes-marketing-deal-for-polpharmas-potential-tysabri-biosimilar/

Four Key Reasons to Attend SMi’s 2019 Biosimilars Conference

https://pharmaphorum.com/partner-content/four-key-reasons-to-attend-smis-2019-biosimilars-conference/

Search